Delivery Order SPE2DB20D3101-SPE2DB23FRMX0

Award Date 5/30/23
Potential Completion Date 5/31/23
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,387.32, is for the delivery of RETACRIT 10,000 UNIT/ML VIAL medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2024. This award is not associated with a set-aside designation, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,632.76, is for the delivery of RETACRIT 20,000 UNIT/ML VIALML and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at one thousand four hundred eighty-three dollars and eighteen cents ($1,483.18) from the Defense Logistics Agency (DLA) Troop Support Medical supply chain to provide 10,000 units of Retacrit, a brand name medication used to treat anemia. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to DLA facilities in Conshohocken, Pennsylvania by October 31, 2023. No set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,144.26 firm-fixed-price contract is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to various government agencies, including the DLA and the Department of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "RIASTAP VIALS" medical supplies, with a ceiling value of $1,652.58 and a completion date of June 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a $2,521.68 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 40,000 units of PROCRIT 40,000 units/mL vials, with a completion date of January 4, 2024. This delivery order is part of Amerisourcebergen's broader indefinite delivery contract with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,348.46 contract is for the supply of 20,000 units of the medication PROCRIT (2 mL vials) with a completion date of May 19, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 20,000 units of PROCRIT 20,000 units/mL vial medication. The $4,210.78 firm-fixed-price contract was awarded on April 29, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,024.40 firm fixed-price delivery order is for the provision of REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRMX0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,547.43 firm fixed-price contract is for the supply of RETACRIT 10,000 UNIT/ML VIALML, a specialty medication. The contract has an ultimate completion date of May 31, 2023 and was awarded on May 30, 2023. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 10:34 AM